Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5427)
Phio Pharmaceuticals Corp. (PHIO)
Plott Ronald Todd — Director
Shares
15,000
Price
$1.14
Total Value
$17.10K
Shares Held After
15,000
% of Holdings
100.0%
CARDINAL HEALTH INC (CAH)
Hollar Jason M. — Chief Executive Officer
Shares
6,244
Price
$237.88
Total Value
$1.49M
Shares Held After
190,603
% of Holdings
3.2%
CARDINAL HEALTH INC (CAH)
Hollar Jason M. — Chief Executive Officer
Shares
16,187
Price
$237.23
Total Value
$3.84M
Shares Held After
196,847
% of Holdings
7.6%
CARDINAL HEALTH INC (CAH)
Hollar Jason M. — Chief Executive Officer
Shares
6,731
Price
$236.46
Total Value
$1.59M
Shares Held After
213,034
% of Holdings
3.1%
CARDINAL HEALTH INC (CAH)
Hollar Jason M. — Chief Executive Officer
Shares
5,704
Price
$235.34
Total Value
$1.34M
Shares Held After
219,765
% of Holdings
2.5%
CARDINAL HEALTH INC (CAH)
Hollar Jason M. — Chief Executive Officer
Shares
3,457
Price
$234.29
Total Value
$809.94K
Shares Held After
225,469
% of Holdings
1.5%
CARDINAL HEALTH INC (CAH)
Hollar Jason M. — Chief Executive Officer
Shares
6,206
Price
$233.22
Total Value
$1.45M
Shares Held After
228,926
% of Holdings
2.6%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
50,000
Price
$74.06
Total Value
$3.70M
Shares Held After
142,265
% of Holdings
26.0%
Camp4 Therapeutics Corp (CAMP)
Tardiff Daniel — Chief Scientific Officer
Shares
1,738
Price
$4.76
Total Value
$8.27K
Shares Held After
0
% of Holdings
100.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,200
Price
$107.77
Total Value
$344.85K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,600
Price
$107.22
Total Value
$1.03M
Shares Held After
770,980
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,200
Price
$106.36
Total Value
$765.78K
Shares Held After
780,580
% of Holdings
0.9%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
30,918
Price
$1.65
Total Value
$50.89K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
31,000
Price
$1.65
Total Value
$51.03K
Shares Held After
48,750
% of Holdings
38.9%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,892
Price
$18.19
Total Value
$88.99K
Shares Held After
77,786
% of Holdings
5.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
2,778
Price
$117.55
Total Value
$326.55K
Shares Held After
0
% of Holdings
100.0%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
77
Price
$394.26
Total Value
$30.36K
Shares Held After
1,035
% of Holdings
6.9%
Shares
10,000
Price
$0.06
Total Value
$590.00
Shares Held After
9,365,456
% of Holdings
0.1%
WEED, INC. (BUDZ)
BREEN NICOLE M — Director
Shares
50,000
Price
$0.03
Total Value
$1.50K
Shares Held After
29,869,930
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
12,757
Price
$5.49
Total Value
$70.00K
Shares Held After
13,705
% of Holdings
93.1%
Tempus AI, Inc. (TEM)
Bartolucci Ryan M — Chief Accounting Officer
Shares
6,175
Price
$49.61
Total Value
$306.34K
Shares Held After
67,866
% of Holdings
8.3%
Tempus AI, Inc. (TEM)
Rogers James William — Chief Financial Officer
Shares
22,529
Price
$49.61
Total Value
$1.12M
Shares Held After
132,337
% of Holdings
14.5%
Ceribell, Inc. (CBLL)
Blumberg Scott — Chief Financial Officer
Shares
990
Price
$25.00
Total Value
$24.75K
Shares Held After
148,121
% of Holdings
0.7%
Tempus AI, Inc. (TEM)
Polovin Andrew — EVP, Chief Legal Officer
Shares
22,148
Price
$49.61
Total Value
$1.10M
Shares Held After
146,067
% of Holdings
13.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
132,591
Price
$49.61
Total Value
$6.58M
Shares Held After
2,098,130
% of Holdings
5.9%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
41,095
Price
$49.61
Total Value
$2.04M
Shares Held After
562,463
% of Holdings
6.8%
Tempus AI, Inc. (TEM)
Schoenherr Thomas Edward — CEO, Diagnostics
Shares
9,232
Price
$49.61
Total Value
$458.00K
Shares Held After
97,797
% of Holdings
8.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
186
Price
$71.98
Total Value
$13.39K
Shares Held After
9,570
% of Holdings
1.9%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
418
Price
$71.98
Total Value
$30.09K
Shares Held After
54,627
% of Holdings
0.8%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
2,199
Price
$25.00
Total Value
$54.98K
Shares Held After
819,214
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
HERSHBERG ROBERT — Director
Shares
15,664
Price
$24.41
Total Value
$382.36K
Shares Held After
46,683
% of Holdings
25.1%
Adaptive Biotechnologies Corp (ADPT)
HERSHBERG ROBERT — Director
Shares
15,000
Price
$24.39
Total Value
$365.85K
Shares Held After
62,347
% of Holdings
19.4%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
918
Price
$5.08
Total Value
$4.67K
Shares Held After
3,180,394
% of Holdings
0.0%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
1,000
Price
$5.15
Total Value
$5.15K
Shares Held After
3,179,476
% of Holdings
0.0%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
1,000
Price
$5.14
Total Value
$5.14K
Shares Held After
3,178,476
% of Holdings
0.0%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
1,000
Price
$5.11
Total Value
$5.11K
Shares Held After
3,177,476
% of Holdings
0.0%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
1,000
Price
$5.10
Total Value
$5.10K
Shares Held After
3,176,476
% of Holdings
0.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
253,080
Price
$0.38
Total Value
$96.17K
Shares Held After
7,914,126
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
1,830
Price
$0.38
Total Value
$695.40
Shares Held After
55,663
% of Holdings
3.2%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
32,676
Price
$45.00
Total Value
$1.47M
Shares Held After
388,044
% of Holdings
7.8%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
45,090
Price
$0.38
Total Value
$17.13K
Shares Held After
1,411,974
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
253,080
Price
$0.38
Total Value
$96.17K
Shares Held After
7,914,126
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,830
Price
$0.38
Total Value
$695.40
Shares Held After
55,663
% of Holdings
3.2%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
45,090
Price
$0.38
Total Value
$17.13K
Shares Held After
1,411,974
% of Holdings
3.1%
Orthofix Medical Inc. (OFIX)
Fisher Patrick — President, Global Limb Recon
Shares
1,295
Price
$10.09
Total Value
$13.07K
Shares Held After
51,219
% of Holdings
2.5%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
OLUKOTUN ADEOYE Y — Director
Shares
2,000
Price
$86.96
Total Value
$173.92K
Shares Held After
31,600
% of Holdings
6.0%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,293
Price
$3.38
Total Value
$7.75K
Shares Held After
1,056,594
% of Holdings
0.2%
Cigna Group (CI)
Jones Nicole S — EVP, Chief Administrative Officer and Chief Human Resources Officer
Shares
2,677
Price
$279.61
Total Value
$748.52K
Shares Held After
25,880
% of Holdings
9.4%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
PERRY MICHAEL S — Director
Shares
11,600
Price
$87.30
Total Value
$1.01M
Shares Held After
111,459
% of Holdings
9.4%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
3,481
Price
$338.50
Total Value
$1.18M
Shares Held After
2,301,375
% of Holdings
0.2%
Showing 2351–2400 of 5427 transactions (page 48 of 109)